Unexpected suppression of anti-Fya and prevention of hemolytic disease of the fetus and newborn after administration of Rh immune globulin

Transfusion

Volumn 51, Issue 4, 2011, Pages 816-819

  Branch, Donald R ^a,b,c   Scofield, Terry L ^a,b,c   Moulds, John J ^a,b,c   Swanson, Jane L ^a,b,c  

^a CANADIAN BLOOD SERVICES   (Canada)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c LifeShare Blood Centers   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; RHESUS D ANTIBODY;

ADULT; AMNIOCENTESIS; ANEMIA; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BILIRUBIN BLOOD LEVEL; CASE REPORT; DIAGNOSTIC TEST; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NEWBORN; NEWBORN HEMOLYTIC DISEASE; PHOTOTHERAPY; PROPHYLAXIS; SALINE TUBE INDIRECT ANTIGLOBULIN TEST;

ADULT; ERYTHROBLASTOSIS, FETAL; FEMALE; FETUS; HUMANS; INFANT, NEWBORN; ISOANTIBODIES; PREGNANCY; RHO(D) IMMUNE GLOBULIN; YOUNG ADULT;

EID: 79954583067     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02905.x     Document Type: Article

References (11)

1. Kumpel B,. On the immunological basis of Rh immune globulin (anti-D) prophylaxis. Transfusion 2006; 46: 1652-6.
2. Kennedy MS,. Perinatal issues in transfusion practice. In:, Roback JD, editor. Technical manual. 16th ed. Bethesda (MD): American Association of Blood Banks; 2008. p. 625-37.
3. Kumpel BM, Elson CJ,. Mechanism of anti-D-mediated immune suppressiona′a paradox awaiting resolution? Trends Immunol 2001; 22: 26-31. (Pubitemid 32675277)
4. Kumpel BM,. On the mechanism of tolerance to the Rh D antigen mediated by passive anti-D (Rh D prophylaxis). Immunol Lett 2002; 82: 67-73. (Pubitemid 34468036)
5. Finn R, Clarke CA, Donohue WT, McConnell RB, Sheppard PM, Lehane D, Kulke W,. Experimental studies on the prevention of Rh haemolytic diseae. Br Med J 1961; 1: 1486-90.
6. Freda VJ, Gorman JG, Pollack W,. Successful prevention of experimental Rh sensitization in man with an anti-Rh gamma2-globulin antibody preparation. A preliminary report. Transfusion 1964; 4: 26-32.
7. Branch DR, Shabani F, Lund N, Denomme GA,. Antenatal administration of Rh-immune globulin causes significant increases in the immunomodulatory cytokines transforming growth factor-β and prostaglandin E2. Transfusion 2006; 46: 1316-22. (Pubitemid 44117958)
8. Rushin J, Rumsey DH, Ewing CA, Sandler SG,. Detection of multiple passively acquired alloantibodies following infusions of IV Rh immune globulin. Transfusion 2000; 40: 551-4. (Pubitemid 30333880)
9. Siragam V, Brinc D, Crow AR, Song S, Freedman J, Lazarus AH,. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease? J Clin Invest 2005; 115: 155-60. (Pubitemid 40385516)
10. Foo AH, Ramkumar S, Helke S, Branch DR,. Chemical treatment of anti-D results in improved efficacy for the inhibition of FcÎ receptor-mediated phagocytosis. Transfusion 2007; 47: 2250-9. (Pubitemid 350151203)
11. Ghio M, Contini P, Negrini S, Proietti M, Gonella R, Ubezio G, Ottonello L, Idiveri F,. sHLA-I contaminating molecules as novel mechanism of ex vivo/in vitro transcriptional and posttranscriptional modulation of transforming growth factor-β1 in CD8+ T lymphocytes and neutrophils after intravenous immunoglobulin treatment. Transfusion 2010; 50: 547-55.